Walgreens to Buy Rite Aid for $9.4 Billion
The move would create a drugstore giant at a time when companies in nearly every corner of the health-care industry are seeking to gain advantage from bulking up.
The benefits of abstaining from alcohol for a month
Benefits of not drinking
Bad news for bacon lovers
WHO: Bacon is dangerous
American Cancer Society’s new guidelines for breast cancer testing
New breast cancer guidelines
Female Viagra hits pharmacy shelves
Female libido drug goes on sale
Wheels Up’s unique way to support breast cancer awareness
Fly to beat breast cancer
Is whole milk actually good for you?
Whole milk OK for you?
Should I get a flu shot?
The return of flu season
Ann Romney: I feel like Mitt is an outsider
Ann Romney on 2016 race, MS
Ann Romney on her battle with MS
Ann Romney on new book
Medicare paying $30M for mystery ambulance rides?
Medicare fraud?
Whistleblowers say retaliation by VA supervisors continues, a year after scandal
The Department of Veterans Affairs continues to retaliate against whistleblowers despite repeated pledges to stop punishing those who speak up, a national group said Tuesday.
Iowa company gets first USDA-issued conditional license to develop bird flu vaccine
An Iowa company has been awarded the first license by the U.S. Department of Agriculture to develop a bird flu vaccine.
APNewsBreak: UK firm asking if its drug is in Arkansas execution plan; state cites secrecy law
A British pharmaceutical company that told Arkansas not to use its products during executions is trying to determine if the state plans to use them anyway, but prison officials are dismissing inquiries about the drug by citing a new law that makes all execution policies an official state secret.
Universal Health Services says it will buy addiction treatment network Foundations for $350M
Universal Health Services, one of the largest hospital operators in the U.S., said Friday it will buy addiction treatment facility company Foundations Recovery Network for $350 million.
Dr. Travis Stork on Alzheimer’s disease, tech in health care
Computers and health care
Perrgo urges shareholders to reject Mylan's $27.14 billion hostile takeover offer
Perrigo urged shareholders to reject Mylan's $27 billion hostile takeover offer, saying it undervalues the company.
Mylan initiates $27.14B bid for Perrigo in an attempt to consolidate generic drug position
Shares of Mylan are up 2 percent before the opening bell after the pharmaceutical company went ahead with its hostile, $27.14 billion bid for Perrigo.
Gilead Sciences rises as Wall Street links $10B debt offering to possible acquisition
Shares of Gilead Sciences rose Thursday after the hepatitis C drugmaker said it will issue $10 billion in debt, leading to speculation that it may be getting ready to make a big acquisition.













